1. Field of Invention
The invention is directed to generic types of inhalers.
2. Description of Related Art
In the treatment of asthma, COPD, diabetes, systemic pain etc., which can be treated by inhalation of a drug medium, inhalation devices with a bulk of medical drugs are widely used.
Normally, two different medical drug formulations are used—one providing the drug in dry powder form (dry powder inhaler=DPI), and one, where the drug is mixed into a suitable propellant in pressurized, liquid form (pressurized metered dose inhaler=pMDI). Liquid phase pressure free drugs, packaged in multi-dose blisters or small bags are also seen. The associated devices incorporate a spring loaded piston to establish a pressure within the blisters or bags.
New regulatory issues require that both DPI's and pMDI's are equipped with a reliable dose indicator, indicating the number of doses left to the patient in the inhaler.
New developments of pharmaceutical formulations, where medical drugs are targeted to be administered via the lungs, especially in diabetes and pain relief, raise new requirements to the accuracy of dose metering and dynamic dose titration such as rapid multiple sequential release of doses within the same inhalation period.
The metering valve should preferably involve few parts and be well suited for automatic assembly and low manufacturing costs.
The pMDI
In the pMDI the medical drug is mixed into a propellant liquid and contained under pressure in a canister. To meter and release the drug in uniform doses, the canister is mounted with a metering valve i. e. as disclosed in U.S. Pat. No. 3,756,465 to Meshberg.
The common valve is a compress-and-release type of valve. From this, the more popular name “press-and-breathe” has been given to the pMDI (
While the patient inhales through the mouthpiece of the pMDI (11) he/she is supposed to manually compress and release the pMDI canister (12) to obtain the inhaled drug, illustrated by the curve in
While inhaling through the mouthpiece, the canister is manually compressed (22), passing the point of release of the previously metered dose (23) until it reaches its fully compressed state (24). After a certain delay (25), the canister is released (26), passing the point of metering of the next dose (27) until it again reaches the fully extended state (28) (reset).
A number of problems are known in present pMDI devices that may result in improper dose release:
The main reasons for inaccurate dose releases are:
Furthermore, there is a risk of drug leaking from the canister to the outside during the delay, as a smaller load is applied to the gaskets inside the metering valve during canister compression. This can lead to a serious lack of drug, when needed by the user.
To overcome the problem of (A) and to improve the coordination between inhalation and dose delivery, breath actuated inhalers (BAI's) have been developed. But as reset must be performed manually by the patient after inhalation, e.g., by closing the cap of the BAI, the risks of (B) and (C) are getting seriously worse.
Canister filling issues:
Rotational metering valves are well known from prior art relating to dry powder inhalers, such as UK Patent Application GB 2165159 to Auvinen. However, these valves are pressure and sealing free, and depend on gravity only.
Rotational dose metering devices for fluids are known from, e.g., gasoline pumps, and within the medical field some examples has been disclosed in U.S. Pat. No. 6,179,583 to Weston and U.S. Pat. No. 6,516,796 to Cox. These valves are designed to work with propellant-free liquids at low pressures, they are complicated and expensive to manufacture and have not been demonstrated to work at the typical canister pressure of 0.3-0.6 MPa.
This invention relates to an inhaler with a sealed rotational metering valve with fixed metering cavities to be used with pressurized canister based aerosol inhalers. The invention solves several of the above mentioned problems inherent with existing pressurized aerosol inhalers:
Activation force is minimized as the metering valve does not need a preloaded return spring.
The metering valve is filled and the metered dose is released in one actuation movement after the user has placed the inhaler in upright position for oral or nasal application. Therefore a full dose will be reliably and accurately metered and problems with long term migration of a former metered dose are avoided.
The need for reset time is obviated, as the liquid in the canister will flow freely into the metering cavity.
In the unidirectional rotational motion mode, the metering valve is unambiguously well suited for a simple counter mechanism; a reliable visual dose indicator is easily attached to the valve.
An embodiment of an elastic sealing member for a ball shaped valve rotor is disclosed that allows for standard canister filling procedures. A filling procedure for a cylindrical shaped valve member is also disclosed.
The forward metering valve can be part of the drug canister/container or it can be an add-on device to the drug canister/container.
A further aspect of the invention is that the forward metering valve is extremely suitable for multi-dose operation, because the mechanical movement of the valve can be rotational, continuous and unidirectional.
a shows one embodiment of a ball shaped forward metering valve.
b shows one embodiment of a conically shaped forward metering valve.
c shows one embodiment of a cylindrically forward metering valve.
a shows an embodiment of the forward metering valve integral within a canister
b shows a principle of filling the canister through the forward metering valve
c shows a filling situation for a cylindrically shaped valve.
d shows the valve in 12c in its closed position after filling.
One possible embodiment of the forward metering valve disclosed in this invention is shown in
The valve rotor (31) shown is ball shaped. The valve rotor contains one or more metering cavities (32). During inhalation the valve rotor (33) is turned within the valve housing (37). In a first position the metering cavity is filled with the container medium through the container outlet (34). In a second position the metered volume in the cavity is enclosed by the wall of the valve housing (37). In a third position the metering cavity releases the dose to the patient through the outlet (35).
Other valve rotor shapes are possible, e.g., conically shaped
b and 3c (36) indicates an example of a sealing structure needed for the valve member primarily to effectively seal the container outlet from the environment to avoid leakage during the full life time and secondly for effective metering and enclosing the dose during rotation until the valve reaches its dose release state. The sealing structure may be integral with the valve rotor (31) or integral with the valve housing (37).
a,
3
b and 3c all show embodiments, where the metering cavities (32) are placed within the valve rotors. It may, however, in some cases be advantageous to place the metering cavity in the valve housing structure. In this case the valve rotor acts merely as a fluid communication controller between the medium in the container, the metering cavity and the valve outlet to the nozzle.
The valve rotor may have a shaft as shown in
Rotational axes depend on the actual embodiment and may be horizontal or vertical or any angle in between.
Valve outlet (35) direction depends on the actual embodiment and may be horizontal or vertical or any angle in between.
Metering cavities may have any form, e.g., cylindrical, square formed, polygonal, and any combinations hereof.
The valve cycles during inhalation are shown in
From an initial filling position (41) the valve rotor (31) is rotated clockwise to the metering position (42) where the metering chamber (32) is isolated from the inlet (34).
After passing the half-way position (43) where the metering chamber is fully closed to the surroundings, the dose release (44) happens when the metering chamber opens up towards the outlet. The last cycle is the stop position (45), which at the same time is the initial position for the next dose. The embodiment shown will rotate approximately 180° to release a dose (2 doses per 360° rotation). Other options are 1, 3, 4, 5, 6 and more doses per 360° rotation.
As the current dose is metered within seconds ahead of delivery, problems (C) and (D) are obviated. There will be no need for priming shots.
Due to the lack of a return spring the force to actuate the metering valve will be significantly lower than 30-50 N, and the effects of problem (A) will be significantly reduced.
As metering of the current dose is done during inhalation (forward metering), it is required to keep the inhaler upright during inhalation. This is far easier to understand for the patient than keeping the inhaler upright after inhalation, decreasing the effect of problem (B).
A potential problem with the proposed valve design is the possibility of feeding outside air and impurities into the pressurized drug bulk, when rotating an emptied metering chamber forward to the inlet position. This can be solved by adding a one-way valve to the outlet of the metering valve, preventing outside air to enter the emptied metering chamber. One possible embodiment of an additional one-way valve is shown in
In the case of the metering valve being integral with the canister, the one-way valve may be placed in an attached nozzle member, still allowing for standard canister filling procedures.
Adding a dose indicator to the proposed valve design will be a simple task. Because the metering valve is only intended to move in one direction, the dose counter can be continuously engaged with the valve and synchronised with the valve movement, eliminating the position tolerance problem and the effects of tampering according to problem (E). One possible embodiment of a dose indicator is shown in
The rotor gear wheel (61) is engaged with the indicator gear wheel (62), ensuring a fixed relation between the number of valve rotations and the position of the visual dose indicator (63). The visual dose indicator (63) can visualise the remaining drug level in the canister by a patterned or coloured field as shown, or it can be fitted with numbers or codes to indicate the approximate or precise number of doses left in the canister.
A potential risk of the proposed valve design in combination with the proposed dose indicator design is the risk of moving the valve backwards, releasing doses while turning the dose indicator backwards. This will lead to lack of synchronisation between the dose indicator status and the actual amount of drug left in the container, which is a serious malfunction of a drug dose indicator. One possible embodiment of a backwards lock is shown in
When adding a backwards lock ratchet (71) to the rotor shaft (33) and a backwards lock spring (72) to the inhaler chassis it will become impossible to move the valve backwards, eliminating the risk of undercounting.
Another potential risk with the proposed valve design is the risk of releasing more doses than required per inhalation. To prevent this, a step lock can be applied. It will ensure that the valve will stop rotating after the required number of doses has been released during inhalation. The step lock can be realised in different embodiments. One possible option is shown in
The valve actuator (81) is mounted free-rotating on the rotor shaft (33). To actuate the valve and release one dose, the valve actuator must be moved clockwise from its upright position resting against the actuator reverse stop (82) to it's downwards position stopped by the actuator forward stop (83). During this, the step lock spring (84) will engage the step lock ratchet (85), rotating the rotor shaft (33) and the valve rotor (31) forward. To prepare the valve for the next dose, the valve actuator (81) must be returned to its upright position, resting against the actuator reverse stop (82). During this, the backwards lock spring (72) will engage the backwards lock ratchet (71), ensuring that the valve rotor (31) will not rotate backwards.
Delivering a single dose with the rotational valve requires a rotational input to the valve shaft to actuate the valve during inhalation. Basically, the valve rotation can be actuated in two different ways:
1. Manual actuation
2. Breath actuation
Manual actuation can be obtained by requiring the user to manually actuate the valve rotation. One possible embodiment is shown in
Another possible embodiment is shown in
Breath actuation can be obtained by using stored energy to actuate the valve rotation.
The stored energy is triggered by the user's inhalation through the inhaler. The energy can be stored in several ways.
In
c and 12d show another solution to the filling requirement F. In this embodiment a cylindrical valve rotor (31) is used and the valve is integral with the container. During assembly of the valve, the valve rotor (31) is not fully inserted into the valve housing (37), thereby enabling the filling of the pressurized medium through the port (126). When the container is filled the valve rotor (31) may be fully inserted, thereby enclosing the medium in the container (12) and the filling port (121) can be removed.
A further aspect of the invention is that the forward metering valve disclosed here is extremely suitable for multi-dose operation, because the mechanical movement of the valve is rotational and unidirectional. The metering cavities can be filled and emptied during rotation at reasonable turning speeds, thus allowing several metered doses to be released during an inhalation sequence.
This aspect unfolds several applications that could solve some problems related to administration of drugs:
Pulmonary administration of insulin is a promising new drug delivery therapy. Unlike most asthma inhalers that deliver the same dose every time, insulin inhalers must be able to preset and deliver different dose sizes dependent of time of day, meals intake, and exercise levels.
Pulmonary administration of pain killers for patients having chronic pain also requires adjustment of doses to the actual pain level.
Inhaler research has indicated that it is advantageous for optimal drug medium deposition to release smaller dose portions during the inhalation sequence shown in
A further aspect of the invention is that the unidirectional rotation of the forward metering valve is easily connected to and driven by a simple motor as shown in
Summing up, the invention relates to a metered dose inhaler for administration a liquid phase medium. It uses a rotating metering element that transports the metered dose from the pressurized canister to the mouthpiece. The metering is improved in that there is an efficient protection against penetration of outside air, and in that the counting of the doses is improved by preventing backwards rotation of the rotating metering element.
The invention has been described in some detail above, but this is not limiting per se, as the skilled person will be able to devise additional mechanical solutions that perform in an equivalent manner, thereby obtaining similar advantageous results.
The foregoing description of the specific embodiments will so fully reveal the general nature of the present invention that others skilled in the art can, by applying current knowledge, readily modify o r adapt for various applications such specific embodiments without undue experimentation and without departing from the generic concept, and therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. The means, materials, and steps for carrying out various disclosed functions may take a variety of forms without departing from the invention.
Thus, the expressions “means to . . . ” and “means for . . . ”, or any method step language, as may be found in the specification above and/or in the claims below, followed by a functional statement, are intended to define and cover whatever structural, physical, chemical, or electrical element or structure, or whatever method step, which may now or in the future exist which carries out the recited functions, whether or not precisely equivalent to the embodiment or embodiments disclosed in the specification above, i.e., other means or steps for carrying out the same function can be used; and it is intended that such expressions be given their broadest interpretation.
Number | Date | Country | Kind |
---|---|---|---|
PA 2006 1483 | Nov 2006 | DK | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/DK07/00500 | 11/14/2007 | WO | 00 | 5/13/2009 |